Evonik Industries AG has inaugurated an Innovation Hub at its Allentown, Pa., site. The Research, Development & Innovation (RD&I) hub is made for several testing and processing labs as well as a pilot plant.
KYOWA HAKKO BIO Co., Ltd has launched a new dietary supplement ingredient IMMUSE, delivering a novel approach for broad-range immune support.
Author Credits: Smruti Ranjan, Rajrani Baghel
Report ID: 4336
Published Date: Feb 05, 2024
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
The growing beauty industry across the globe and the growing sales of smartwatches are the major factors driving the growth of the market.
The market size of hydroxyproline is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2024-2036.
The major players in the market are Henan Senyuan Group Co., Ltd., Evonik Industries AG, Fengchen Group Co.,Ltd, Merck Group, Thermo Fisher Scientific Holdings, Inc., EnColl Corporation, Wuxi Jingyao Biotechnology Co., Ltd., BASF SE, Wuhan Dico Chemical Co., Ltd., and others.
The industrial grade segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.
The market in the Asia Pacific region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.